Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks

Presenter(s)

• 

  Erik Hecht, Pharm D

  Scientific Director, Hemoglobinopathies
  Novo Nordisk Inc.
  Plainsboro, New Jersey, United States

  Slides

Author(s)

• 

  Adam Wufsus, PhD

  Director, Rare Disease Medical
  Novo Nordisk Inc
  Golden, Colorado, United States

Co-Author(s)

• SD

  Sophia Delicou, n/a

  Head of Thalassemia and Sickle Cell Disease Unit,Head of the Expertise Center of Hemoglobinopathies
  Hippokrateio General Hospital Athens
  Rochester, Attiki, Greece
• 

  Fuad El Rassi, MD

  Associate Professor
  Emory University School of Medicine
  Emory University School of Medicine
  Atlanta, Georgia, United States
• 

  Biree Andemariam, MD

  Professor of Medicine
  University of Connecticut Health
  University of Connecticut Health
  Farmington, Connecticut, United States
• MA

  Miguel R. Abboud, MD

  Chairperson and Professor
  American University of Beirut
  Beirut, Beyrouth, Lebanon
• JK

  Julie Kanter, MD

  Medical Director, Sickle Cell Program
  University of Alabama, Birmingham
  University of AL Birmingham
  Birmingham, Alabama, United States
• 

  Marilyn J. Telen, MD

  Professor of Medicine
  Duke University Medical Center
  Duke University
  Durham, North Carolina, United States
• JG

  Jessie Githanga, MMed

  Associate Professor
  University of Nairobi, Nairobi Area, Kenya
• AI

  Adlette Inati, MD

  Professor of Clinical Medicine
  Lebanese American University- Gilbert and Rose Marie School of Medicine
  Tripoli, Beyrouth, Lebanon
• II

  Ibrahim M. Idris, MBBS, MPH

  Consultant Haematologist
  Aminu Kano Teaching Hospital/Bayero University Kano,, Kano, Nigeria
• SN

  Sunil Navani, MD, DPM

  Medical Director
  Novo Nordisk Ltd
  Oxford, England, United Kingdom
• EW

  Eric Wu, PhD

  Associate Director, biostatistics
  Novo Nordisk Inc
  Lexington, Kentucky, United States
• AE

  Andrew Eisenberger, MD

  Director - Classical Hematology
  Columbia University Irving Medical Center
  New York, New York, United States